Postural Stability and Ankle Mobility in Haglund Syndrome

Sponsor
Cairo University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05905952
Collaborator
(none)
25
1
5.7
4.4

Study Details

Study Description

Brief Summary

The purpose of the study is to find out the impact of Haglund syndrome on ankle plantarflexion and dorsiflexion ROM, dynamic postural stability and fall risk.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: balance and ROM assessment

Detailed Description

This study will be delimited to:
  • Total sample size is fifty participants, twenty five patient of symptomatic Haglund syndrome of both gender and twenty five healthy volunteers of matched age, sex and body mass index without any musculoskeletal complaints of the lower limbs.

  • Biodex balance system will be used to determine postural stability.

  • Ankle plantarflexion and dorsiflexion range of motion will be measured using an Electrogoniometer.

  • Age of the patients 25-56

  • BMI of (18.5 to 24.9)

Participants:

Fifty volunteers from both genders will participate in the study. They will be assigned from outpatient clinic of Faculty of Physical Therapy, Deraya University. They will be interviewed and divided to twenty five patient of Haglund syndrome as (patient group) after being diagnosed and referred by orthopedic surgeon and twenty five Healthy volunteers as (control group) based on the following inclusion and exclusion criteria:

Study Design

Study Type:
Observational
Anticipated Enrollment :
25 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Evaluation of Postural Stability and Ankle Mobility in Haglund Syndrome
Actual Study Start Date :
Mar 12, 2023
Anticipated Primary Completion Date :
Jul 30, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
patient group

to twenty five patient of Haglund syndrome as (patient group) after being diagnosed and referred by orthopedic surgeon and twenty

Diagnostic Test: balance and ROM assessment
assessment of postural stability and ankle range of motion

control group

twenty five Healthy volunteers as (control group) based on the following inclusion and exclusion criteria

Diagnostic Test: balance and ROM assessment
assessment of postural stability and ankle range of motion

Outcome Measures

Primary Outcome Measures

  1. postural stability test report [1 day]

    a measurement of the antero-posterior, medio-lateral and overall stability and range of motion

  2. ankle range of motion test [1 day]

    measuring of ankle planter and dorsiflexion range of motion with digital goniometer

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 56 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • For patient group:

  • Patient referred from orthopedic surgeon with diagnoses as Haglund syndrome according to the following signs and symptoms

  • Calcaneal prominence diagnosed on lateral weight bearing radiograph with bony prominence superior to parallel pitch lines or posterior calcaneal angle greater than 75 degrees

  • Pain medially at insertion of tendo-achilles

  • Palpation of hard, bony prominence

  • Pain upon rising out of bed

  • Both unilateral and bilateral cases, and in consideration of dealing with bilateral cases the tested limb will be the most painful limb.

  • Age of 25-56 years

  • Both males and females.

  • BMI of (18.5 to 24.9)

For control group:

Healthy volunteers of matched age, sex and body mass index without any musculoskeletal complaints of the lower limbs and will be included in the control group in this study .

Exclusion Criteria:
  • Musculoskeletal disorders except Haglund syndrome

  • cognitive disorder, visual impairment that affected their daily living and any further medical condition that would prohibit them from participating safely in the chosen balance measures

  • sensory loss at foot or ankle and with a systemic inflammatory disease, such as diabetes mellitus, peripheral neuropathy, rheumatoid arthritis and ankylosing spondylitis, who had undergone corticosteroid injections or physical therapy in the last three months

  • Patients with vestibular or neurological disorders

  • Any other cause of posterior heel pain.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Deraya University Minya Egypt 05673

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: enas F youssif, prof, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nassif Magdy Mousa, principle investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT05905952
Other Study ID Numbers:
  • P.T.REC/ 012/004497
First Posted:
Jun 15, 2023
Last Update Posted:
Jun 15, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2023